These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35466959)

  • 1. Response to "An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris".
    Mungmunpuntipantip R; Wiwanitkit V
    Int J Risk Saf Med; 2022; 33(3):333. PubMed ID: 35466959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pityriasis rubra pilaris after COVID-19 vaccination: causal relationship or coincidence?].
    Bramhoff AC; Wesselmann U; Bender ST; Berghoff AV; Hofmann SC; Balakirski G
    Dermatologie (Heidelb); 2022 Aug; 73(8):634-637. PubMed ID: 35296923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine.
    Sechi A; Pierobon E; Pezzolo E; Germi L; Trevisan G; Zardo D; Riva G; Mondino S; Naldi L
    Clin Exp Dermatol; 2022 Feb; 47(2):437-440. PubMed ID: 34617317
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on: 'Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine'.
    Mungmunpuntipantip R; Wiwanitkit V
    Clin Exp Dermatol; 2022 Jun; 47(6):1195-1196. PubMed ID: 35187721
    [No Abstract]   [Full Text] [Related]  

  • 5. Pityriasis rubra pilaris following booster dose of mRNA (Pfizer-BioNTech) COVID-19 vaccine.
    Hlaca N; Zagar T; Kastelan M; Peternel S; Brajac I; Dujmovic-Hasanbegovic K; Prpic-Massari L
    Dermatol Ther; 2022 Nov; 35(11):e15791. PubMed ID: 36029037
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on 'Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine'.
    Potestio L; Genco L; Noto M; Fabbrocini G; Battista T; Martora F
    Clin Exp Dermatol; 2023 Jan; 48(1):44-45. PubMed ID: 36669180
    [No Abstract]   [Full Text] [Related]  

  • 7. Pityriasis rubra pilaris following inactivated SARS-CoV-2 vaccine (CoronaVac).
    Zhang LW; Wang WJ; Fu LX; Lu YH; Chen T; Xu RH
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):e287-e288. PubMed ID: 36504416
    [No Abstract]   [Full Text] [Related]  

  • 8. Pityriasis rubra pilaris in association with inactivated SARS-CoV-2 vaccine (CoronaVac).
    Fernández LT; Pérez-Garza DM; delaO-Escamilla A; Yamallel-Ortega LA; Cuellar-Barboza A; Ocampo-Candiani J; Chavez-Alvarez S
    Dermatol Ther; 2022 Jun; 35(6):e15455. PubMed ID: 35297142
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythrodermic Pityriasis Rubra Pilaris Following COVID-19 Vaccination.
    Abdelkader HA; Khedr H; El-Komy MH
    Cutis; 2024 Apr; 113(4):E22-E24. PubMed ID: 38820101
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythrodermic pityriasis rubra pilaris after SARS-CoV-2 vaccination with concomitant COVID-19 infection.
    Gambichler T; Scheel CH; Arafat Y; Kautz O; Boms S
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e675-e676. PubMed ID: 35536694
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment on: 'Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination' by Gambichler.
    Potestio L; Martora F; Villani A; Megna M; Ruggiero A
    J Eur Acad Dermatol Venereol; 2023 Oct; 37(10):e1196-e1197. PubMed ID: 37326210
    [No Abstract]   [Full Text] [Related]  

  • 12. Pityriasis rubra pilaris after COVID-19 vaccination: successful treatment with ustekinumab.
    Vieira Granja B; Amoedo P; Gomes NP; Costa C; Azevedo F; Magina S
    An Bras Dermatol; 2024; 99(4):642-644. PubMed ID: 38653608
    [No Abstract]   [Full Text] [Related]  

  • 13. Pityriasis rubra pilaris after Vaxzevria® COVID-19 vaccine.
    Lladó I; Butrón B; Sampedro-Ruiz R; Fraga J; de Argila D
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e833-e835. PubMed ID: 34310778
    [No Abstract]   [Full Text] [Related]  

  • 14. An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris.
    Sahni MK; Roy K; Asati DP; Khurana U
    Int J Risk Saf Med; 2021; 32(4):261-264. PubMed ID: 34420983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pityriasis rubra pilaris (type I) following administration of the BNT162b2 mRNA COVID-19 vaccine: Successful treatment with ustekinumab and acitretin.
    Gamonal SBL; Marques NCV; Pereira HMB; Gamonal ACC
    Dermatol Ther; 2022 Dec; 35(12):e15899. PubMed ID: 36196603
    [No Abstract]   [Full Text] [Related]  

  • 16. Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine.
    Hunjan MK; Roberts C; Karim S; Hague J
    Clin Exp Dermatol; 2022 Jan; 47(1):188-190. PubMed ID: 34379821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pityriasis rubra pilaris post-infection due COVID-19: case report.
    Aguilar-Gamboa FR; Cubas-Alarcon D; Villegas-Chiroque M; Failoc-Rojas VE
    Colomb Med (Cali); 2021 Mar; 52(1):e7014577. PubMed ID: 33911322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatomyositis with a pityriasis rubra pilaris-like eruption: an uncommon cutaneous manifestation in dermatomyositis.
    Polat M; Lenk N; Ustün H; Oztaş P; Artüz F; Alli N
    Pediatr Dermatol; 2007; 24(2):151-4. PubMed ID: 17461814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple basaliomas in pityriasis rubra pilaris].
    Zabel M; Panteleos D
    Hautarzt; 1979 Oct; 30(10):537-9. PubMed ID: 521276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute postinfectious type III pityriasis rubra pilaris as a cutaneous manifestation in COVID-19: Decoding a possible trigger!!
    Arora A; Mohta A; Ghiya BC; Kumar Jangir V
    J Cosmet Dermatol; 2022 Aug; 21(8):3206-3207. PubMed ID: 35332643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.